29/12/2009
Cell Therapeutics, Inc.
SEATTLE, Dec. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") rejected and dropped a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right could be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Subscribe to:
Post Comments (Atom)
SOUTH AFRICA SPRINGBOKS
South Africa laid the groundwork with traditional Springbok rugby and finished an out-gunned England side off with two late tries to win ...
-
Ending November we saw a decline in the Crude price as oil fell below $90 a barrel in the biggest weekly loss in two and a half years on con... -
South Africa is the biggest source of coal for European power plants and the world's biggest producer of ferrochrome, manganese and vana...
-
The average price in Europe on Super95 for the past two weeks has raised at € 0.01 and now is € 1.17. Super95 is the most common type of f...
No comments:
Post a Comment